BIIB - BIOGEN INC. (NASDAQ: BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline | Benzinga
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
- Do you, or did you, own shares of Biogen Inc. (NASDAQ:BIIB)?
- Did you purchase your shares between February 3, 2022 and February 13, 2024, inclusive?
- Did you lose money in your investment in Biogen Inc.?
- Do you want to discuss your rights?
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Biogen Inc. ("Biogen" or the "Company") (NASDAQ:BIIB) between February 3, 2022 and February 13, 2024, inclusive (the "Class Period"). The lawsuit was filed in the United States District Court for the District of Colorado and alleges violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the "Complaint").
If you purchased or acquired Biogen securities, and/or would like to discuss your legal rights and options please visit Biogen Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.
If you wish to serve as lead plaintiff, you must move the Court no later than July 22, 2024. A lead plaintiff is a representative party acting on behalf ...
BIIB) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Biogen Inc. Investors of Upcoming Deadline>Full story available on Benzinga.com